Q2 FY26 results: standalone revenue up 48% YoY, PAT jumps 4.5x; WesTech deal cleared

Revenue growth above 20%Profit growth above 25%Results View source PDF Explain this filing

JASH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.5%Reaction day

₹485.40

prior close

₹483.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%+0.6% vs market

Industrial Products peers, median of 114sector-0.1%+0.6% vs sector

On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 0.6 pts more than its Industrial Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

-0.6

15m

-0.8

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.5-0.1+0.6-0.1+0.6

Next day

-0.8+0.5-1.3-0.3-0.6

-3.4-0.3-3.1-2.1-1.3

-3.6-0.5-3.1-2.1-1.5

-3.0-0.8-2.2-2.3-0.7

-3.9-2.3-1.6-3.6-0.3

-5.0-2.8-2.2-5.3+0.2

15d

-8.3-4.9-3.5-6.5-1.8

-9.0-4.7-4.3-6.8-2.2

-16.3-7.7-8.5-12.7-3.6

-17.7-7.8-9.9-14.7-3.0

UpDownMarket · Nifty Microcap 250Sector · Industrial Products peers, median of 114Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q2 and H1 FY26 unaudited results. Standalone Q2 revenue rose 48 percent YoY to Rs 114.24 crore with PAT at Rs 17.42 crore versus Rs 3.15 crore in Q2 FY25, EPS Rs 2.77. Consolidated Q2 revenue stood at Rs 157.54 crore with PAT of Rs 10.97 crore. Board approved proposed acquisition of Wes Tech Process Equipment India and noted due diligence on Penstocks UK buyout. Auditor Deloitte Haskins and Sells issued a clean limited review with no qualifications.

Likely market impact

Strong standalone Q2 show and WesTech acquisition approval should lift investor sentiment; consolidated H1 PAT softness merits watch.